Signal
New studies reveal molecular and clinical heterogeneity in cardiovascular and metabolic syndromes
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-06-18 23:00 UTCUpdated 2026-06-19 02:57 UTC
rss
clinical_trialsdrug_developmentsafety_signalsgenomicsr_and_d
Trend in the last 24h
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
Recent large-scale studies highlight the complex molecular and clinical heterogeneity underlying cardiovascular disease and mortality risk.
Entities
Yang, Y.Tan, D.Carrasco-Zanini, J.Su, C.-Y.Zhou, S.Koyama, S.Natarajan, P.Langenberg, C.
Score total
0.72
Momentum 24h
2
Posts
2
Origins
1
Source types
1
Duplicate ratio
0%
Why now
- Large-scale proteomic and epidemiological datasets now enable discovery of novel predictive biomarkers.
- Rising burden of cardiovascular-kidney-metabolic syndromes demands improved prognostic tools.
- Integration of multi-dimensional biomarkers is a frontier in precision cardiometabolic medicine.
Why it matters
- Improved molecular and physiological markers enable better risk stratification for cardiovascular diseases.
- Understanding heterogeneity supports development of targeted interventions and personalized medicine.
- Cross-cohort validation enhances confidence in biomarkers across populations.
LLM analysis
Topic mix: lowPromo risk: lowSource quality: medium
Recurring claims
- A 320-protein plasma panel improves prediction of incident coronary artery disease beyond traditional clinical risk scores.
- Combined indices of inflammation, metabolic markers, frailty, and cardiorespiratory fitness predict all-cause and cardiovascular mortality in adults with cardiovascular-kidney-metabolic syndrome.
How sources frame it
- Yang Et Al.: neutral
- An Et Al.: neutral
This narrative synthesizes recent preprints that advance understanding of cardiovascular disease heterogeneity through proteomics and integrated clinical indices, highlighting opportunities for precision medicine.
All evidence
All evidence
Joint association of C-reactive protein-triglyceride glucose index-frailty index and non-exercise estimated cardiorespiratory fitness with all-cause mortality in adults aged >=4...
medRxiv (all subjects) · medrxiv.org · 2026-06-19 02:57 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 1Origin domains: 1Duplicates: -
Showing 1 / 0
Top publishers (this list)
- medRxiv (all subjects) (1)
Top origin domains (this list)
- medrxiv.org (1)